J

João Pedro Ferreira

ORCID: 0000-0002-2304-6138

Publishes on Heart Failure Treatment and Management, Diabetes Treatment and Management, Cardiovascular Function and Risk Factors. 582 papers and 21.3k citations.

PubIndex Score88Top 12% · seniorHow it's scored

582Publications

21.3kTotal Citations

First publication: 1938First senior author: 1938

Heart Failure Treatment and Management Diabetes Treatment and Management Cardiovascular Function and Risk Factors Hormonal Regulation and Hypertension Hyperglycemia and glycemic control in critically ill and hospitalized patients

Top publicationsby citations

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021

Cited by 4.6k

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

Faı̈ez Zannad, Milton Packer, João Pedro Ferreira et al.|The Lancet|2020

Cited by 1.4k

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Adriaan A. Voors, Piotr Ponikowski, Jan Biegus et al.|Nature Medicine|2022

Cited by 889

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

Muthiah Vaduganathan, Scott D. Solomon, Brian Claggett et al.|The Lancet|2020

Cited by 645

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Milton Packer, Faı̈ez Zannad, Stefan D. Anker et al.|Circulation|2020

Cited by 422